BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/7/2023 7:47:34 AM | Browse: 115 | Download: 295
 |
Received |
|
2022-12-27 20:49 |
|
Peer-Review Started |
|
2022-12-27 20:50 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-22 06:15 |
|
Revised |
|
2023-02-06 07:03 |
|
Second Decision |
|
2023-04-11 03:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-11 17:00 |
|
Articles in Press |
|
2023-04-11 17:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-03-31 22:43 |
|
Typeset the Manuscript |
|
2023-04-23 00:26 |
|
Publish the Manuscript Online |
|
2023-05-07 07:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Perttu Lahtinen, Jonna Jalanka, Eero Mattila, Jyrki Tillonen, Paula Bergman, Reetta Satokari and Perttu Arkkila |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sigrid Juselius Foundation and University of Helsinki (A Three-year Grant) |
|
| Academy of Finland (Reetta Satokari) |
323156 |
| The Competitive State Research Financing (Perttu Lahtinen) |
200230042 |
| The Ella and Georg Ehrnrooth Foundation (Perttu Arkkila) |
|
|
| Corresponding Author |
Perttu Lahtinen, MD, Chief Doctor, Department of Gastroenterology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, Lahti 15610, Finland. perttu.lahtinen@phhyky.fi |
| Key Words |
Fecal microbial transplantation; Ulcerative colitis; Quality of life; Maintenance of remission; Inflammatory bowel disease; Fecal calprotectin |
| Core Tip |
This randomized controlled trial compared the efficacy of Fecal microbial transplantation (FMT) via colonoscopy and autologous placebo containing patients’ own feces for the maintenance of remission in 48 patients with ulcerative colitis. The colitis activity was measured with the clinical Mayo score and fecal calprotectin. There was no significant difference in relapses between the groups at the one-year follow-up. Remission remained in 54% of the patients in the FMT group compared to 41% in the placebo group. There was no difference in the adverse events between the groups. |
| Publish Date |
2023-05-07 07:47 |
| Citation |
Lahtinen P, Jalanka J, Mattila E, Tillonen J, Bergman P, Satokari R, Arkkila P. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial. World J Gastroenterol 2023; 29(17): 2666-2678 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i17/2666.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i17.2666 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
